51
|
Giralt D, Domingues-Montanari S, Mendioroz M, Ortega L, Maisterra O, Perea-Gainza M, Delgado P, Rosell A, Montaner J. The gender gap in stroke: a meta-analysis. Acta Neurol Scand 2012; 125:83-90. [PMID: 21649609 DOI: 10.1111/j.1600-0404.2011.01514.x] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
UNLABELLED Several studies have indicated that gender differences might exist in stroke. OBJECTIVES AND METHODS Our goal was to perform a comprehensive meta-analysis in order to evaluate and quantify stroke gender disparities through a systematic search of relevant articles published up to October 2009 and addressing gender related differences in ischemic stroke risk factors, stroke subtype and severity, diagnostic tests, and acute phase and secondary prevention treatments. RESULTS Forty-five articles were included in the analysis, representing a total of 673,935 patients. Women were globally older than men (+5.2 years) and suffered more hypertension (P = 0.017) and atrial fibrillation (P < 0.001), although they were less likely to drink alcohol (P < 0.001), smoke cigarettes (P < 0.001), present hyperlipidemia (P = 0.033) or diabetes (P = 0.003) than men. Baseline stroke severity was not different between genders. Women suffered more cardioembolic strokes, while men had more atherothrombotic strokes. Moreover, women were less likely to receive stroke-related treatments, such as antiplatelets (P < 0.001), statins (P < 0.001), and tPA (P < 0.001) than men. Although meta-regression did not identify age or stroke etiology as sources of heterogeneity, caution should be taken as that analysis was possible only for gender differences in secondary prevention with antiplatelets because of limited data for other end points. CONCLUSIONS Gender differences have been identified on the risk factors profile and diagnostic and therapeutic management of patients with ischemic stroke. Active measures should thus be taken to avoid bias in clinical practice.
Collapse
|
52
|
Grabowecky M, Ortega L, Nwosu C, Suzuki S, Smith E, Factor L. The Emotional Blink in Novice Meditators. J Vis 2011. [DOI: 10.1167/11.11.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
53
|
Ortega L, Guzman-Martinez E, Grabowecky M, Suzuki S. The time-dilation aftereffect depends on orientation and eye of origin. J Vis 2011. [DOI: 10.1167/11.11.1226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
54
|
Guzman-Martinez E, Ortega L, Grabowecky M, Mossbridge J, Suzuki S. Interactive processing of auditory amplitude-modulation frequency and visual spatial frequency. J Vis 2011. [DOI: 10.1167/11.11.774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
55
|
Martin Broto J, Garcia del Muro X, Gutierrez A, Martinez-Trufero J, Serrano T, Rubió J, Lainez N, Sevilla I, Cruz J, Ramos R, Ortega L, Poveda A, Ramirez M, Cubedo R, Lopez-Guerrero J. KIT, DOG1, PDGFR, and IGFR1 gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10047] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
56
|
Viasus D, Paño-Pardo JR, Pachón J, Riera M, López-Medrano F, Payeras A, Fariñas MC, Moreno A, Rodríguez-Baño J, Oteo JA, Ortega L, Torre-Cisneros J, Segura F, Carratalà J. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest 2011; 140:1025-1032. [PMID: 21415133 DOI: 10.1378/chest.10-2792] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
BACKGROUND Data on the clinical effectiveness of oseltamivir in patients with pandemic 2009 influenza A(H1N1) (A[H1N1]) virus infection are scarce. We aimed to determine the effect of timing of oseltamivir administration on outcomes in hospitalized adults with A(H1N1). METHODS Observational analysis of a prospective cohort of adults hospitalized with laboratory-confirmed A(H1N1) was performed at 13 Spanish hospitals. Time from onset of symptoms to oseltamivir administration was the independent variable. Outcomes were duration of fever, hospital length of stay (LOS), need for mechanical ventilation, and mortality during hospitalization. Multivariate logistic regression was used to describe the association between the independent variable and the outcomes. RESULTS Five hundred thirty-eight hospitalized patients with A(H1N1) were studied. The median time from onset of symptoms to oseltamivir administration was 3 days (interquartile range [IQR], 2-5 days). With regard to outcomes, the median duration of fever was 2 days (IQR, 1-3 days), the median LOS was 5 days (IQR, 3-8 days), 49 patients (9.1%) underwent mechanical ventilation, and 11 patients (2%) died during hospitalization. In univariate analysis, prolonged duration of fever (above the median), prolonged LOS (above the median), need for mechanical ventilation, and mortality all increased with time to oseltamivir administration (χ(2) test for trend P = .001, P ≤ .001, P = .008, and P = .001, respectively). After adjustment for confounding factors, time from onset of symptoms to oseltamivir administration (+ 1-day increase) was associated with a prolonged duration of fever (OR, 1.10; 95% CI, 1.02-1.19), prolonged LOS (OR, 1.07; 95% CI, 1.00-1.15), and higher mortality (OR, 1.20; 95% CI, 1.06-1.35). CONCLUSIONS Timely oseltamivir administration has a beneficial effect on outcomes in hospitalized adults with A(H1N1), even in those who are admitted beyond 48 h after onset of symptoms.
Collapse
|
57
|
Ortega L, Robles N, Matrai S, Gual A. P01-44-The e-mail as a potential therapeutic tool in patients with alcohol dependence: The patient's perspective. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)71755-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
IntroductionThe use of Internet-based communication tools has spread to multiple areas of life. E-mail is a fast and easy tool that can be used by the health care system to facilitate doctor-patient communication.ObjectivesTo assess the use and value of the e-mail for communication between physician and patient, from patients’ perspective.AimsTo evaluate the use of e-mail as a potential therapeutic tool in patients with alcohol dependence.MethodsThe sample included patients who reported to have an e-mail account at their first visit in Alcohol Unit (n = 44 of 238 patients seen during one year). 23 patients were given the contact e-mail of the Alcohol Unit, and were instructed to contact their physician, if needed, by e-mail. The rest of the sample (n = 21) could contact their physician only by phone. Six months later, the whole sample received an electronic survey measuring their satisfaction of the communication with the physician.Results57% patients who received the contact e-mail of the Alcohol Unit answered the survey (n = 13). Of those, 54% used e-mail to contact their physician. 71% found e-mail easy-to-use; 86% reported being satisfied with e-mail communication.ConclusionsE-mail contact with physician was considered useful by most patients, although they report using also other contact methods, such as phone call.
Collapse
|
58
|
Nunez - Calonge R, Guijarro JA, Ortega L, Olaya E, Cortes S, Gosalvez J, Caballero P, Franco G, Scarselli F, Zavaglia D, Dente D, Minasi MG, Greco E, Serzedello T, Semaco EO, Nichi M, Barnabe VH, Serafini P, Motta ELA, Rocha AM, Garrido N, Remohi J, Gil-Salom M, Martinez-Javaloyas JM, Pellicer A, Chen C, Hu JCY, Neri QV, Rosenwaks Z, Palermo GD. SELECTED ORAL COMMUNICATION SESSION, SESSION 19: ANDROLOGY - MALE AND SEMEN FACTORS, Monday 4 July 2011 15:15 - 16:30. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
59
|
Caballero Peregrin P, Nunez-Calonge R, Guijarro JA, Ortega L, Cortes S, Gosalvez J, Palini S, De Stefani S, Scala V, Benedetti S, Tagliamonte MC, Catalani S, Primiterra MA, Polli V, Rocchi P, Tiezzi A, Donati L, Pelosi E, Canestrari F, Bulletti C, Garcia-Herrero S, Meseguer M, Martinez-Conejero JA, Romany L, Ruiz M, Horcajadas JA, Pellicer A, Garrido N, Ramon O, Corcostegui B, Crisol L, Exposito A, Mugica J, Matorras R, Kyurkchiev S, Dyulgerova-Nikolova D, Milachich T, Shterev A, Pons Mallol I, Cercas Duque R, Villas Martin C, Brana Pelayo C, Fernandez Shaw S, Arts EGJM, Wester NE, Groen H, van Echten-Arends J, Land JA. SELECTED ORAL COMMUNICATION SESSION, SESSION 70: ANDROLOGY AND SEMINAL FACTORS Wednesday 6 July 2011 14:00 - 15:45. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.70] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
60
|
|
61
|
Cuenca F, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Suárez A, Ortega L, Díaz-Rubio M, Ladero JM. Predictive baseline criteria of primary therapeutic failure in chronic hepatitis C genotype 1. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2010; 102:234-8. [PMID: 20486745 DOI: 10.4321/s1130-01082010000400003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND AND AIMS more than half of patients with genotype 1 chronic hepatitis C (CHC) do not achieve a sustained viral response (SVR) to current antiviral therapy due to primary non-response, relapse or intolerance. Factors related to each of these unfavorable outcomes are different and the last two may be partially prevented. Our aim was to identify basal criteria to predict the risk of primary failure. PATIENTS AND METHODS we included 251 consecutive patients (152 males) from a single centre, infected with HCV genotype 1 and not previously treated. SVR was achieved in 141 patients and primary failure in 110. RESULTS high vs. low viral load (> 400,000 IU/mL, OR = 6.17; 95% CI: 2.50-15.23), high serum GGT (> 60 IU/mL, OR = 4.25; 95% CI: 2.49-7.24), low serum cholesterol ( < 178 mg/dL, OR = 2.93; 95% CI: 1.75-4.92) and older age (> 47 yrs., OR = 1.79; 95% CI: 1.08-2.96) were associated to the risk of primary failure in the lineal logistic regression analysis. From the 58 patients carrying all the first three negative criteria, 46 (79.3%) were primary non-responders. CONCLUSIONS the negative basal profile identified in this study is based on easily available data and provides information about the risk of primary therapeutic failure, and may help to decide whether antiviral therapy should be offered to a single patient.
Collapse
|
62
|
Ortega L, Guzman-Martinez E, Grabowecky M, Suzuki S. Orientation-specific flicker adaptation dilates static time. J Vis 2010. [DOI: 10.1167/10.7.1415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
63
|
Antonucci N, Stronati A, Manes S, Corradetti B, Manicardi GC, Borini A, Bizzaro D, Cortes S, Ortega L, Gosalvez J, Lopez-Fernandez C, Orozco I, Gago M, Nunez R, Hammadeh M, Hamad M, Montenarh M, Fischer-Hammadeh C, Mauri AL, Petersen CG, Massaro FC, Silva LFI, Vagnini LD, Junta CM, Felipe V, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco JG, Agarwal A, Sharma RK, Gupta S, Thiyagarajan A, Sabanegh E. Session 16: New Approaches for Sperm DNA Testing. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
64
|
Ortega L, Guzman-Martinez E, Grabowecky M, Suzuki S. Auditory dominance in time perception. J Vis 2010. [DOI: 10.1167/9.8.1086] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
65
|
Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Ortega L, Agreda M, Suárez A, Ropero P, Díaz-Rubio M. Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2009; 101:31-40. [PMID: 19335031 DOI: 10.4321/s1130-01082009000100004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND Hyperferritinemia is often found in patients with chronic hepatitis C (CHC) and is predictive of poorer response to antiviral therapy. OBJECTIVE To investigate changes in ferritinemia during and after antiviral therapy. PATIENTS AND METHODS serum ferritin levels were measured in 262 CHC patients (163 males, mean age 48.5 years +/- 10.1) before and during antiviral therapy, and six months post-treatment in all 154 patients with undetectable serum HCV-RNA after therapy completion. RESULTS Baseline serum ferritin was higher in patients with primary therapeutic failure than in those reaching sustained viral response (330 +/- 291 ng/mL vs. 211 +/- 192 ng/mL, p = 0.002). Serum ferritin transiently increased during therapy from baseline (257 +/- 242 ng/mL vs. 875 +/- 630 ng/mL, p < 0.001). Six months after finishing therapy, serum ferritin decreased under baseline values both in sustained responders (117 +/- 102 ng/mL vs. 211+/- 192 ng/mL, p < 0.001) and, to a lesser extent, in relapsers (217 +/- 174 ng/mL vs. 257 +/- 221 ng/mL, p = 0.047). CONCLUSIONS Baseline serum ferritin may predict response to antiviral treatment in chronic hepatitis C. Combined antiviral therapy induces a marked increase in serum ferritin that falls below baseline values after sustained viral response, suggesting that the cause of hyperferritinemia in many patients is HCV infection itself rather than iron overload.
Collapse
|
66
|
Martin-Ventura JL, Madrigal-Matute J, Munoz-Garcia B, Blanco-Colio LM, Van Oostrom M, Zalba G, Fortuno A, Gomez-Guerrero C, Ortega L, Ortiz A, Diez J, Egido J. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovasc Res 2009; 83:586-94. [DOI: 10.1093/cvr/cvp141] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
67
|
Sanchez-Galan E, Gomez-Hernandez A, Vidal C, Martin-Ventura JL, Blanco-Colio LM, Munoz-Garcia B, Ortega L, Egido J, Tunon J. Leukotriene B4 enhances the activity of nuclear factor- B pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc Res 2008; 81:216-25. [DOI: 10.1093/cvr/cvn277] [Citation(s) in RCA: 103] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
|
68
|
Goujon C, Darie C, Bacia M, Klein H, Ortega L, Bordet P. High pressure synthesis of BiCrO3, a candidate for multiferroism. ACTA ACUST UNITED AC 2008. [DOI: 10.1088/1742-6596/121/2/022009] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
69
|
Herrero-Beaumont G, Marcos ME, Sánchez-Pernaute O, Granados R, Ortega L, Montell E, Vergés J, Egido J, Largo R. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 2008; 154:843-51. [PMID: 18536737 PMCID: PMC2439856 DOI: 10.1038/bjp.2008.113] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2007] [Revised: 01/30/2008] [Accepted: 02/13/2008] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND AND PURPOSE Among the agents employed to manage osteoarthritis, chondroitin sulphate (CS) is a natural glycosaminoglycan with an anti-inflammatory effect on joint cells. CS might also influence the inflammatory component of atherosclerosis. Our aim was to examine the effect of CS administration on vascular injury and on markers of systemic inflammation in a rabbit model of atherosclerosis aggravated by systemic inflammation provoked by chronic antigen-induced arthritis. EXPERIMENTAL APPROACH Atherosclerosis was induced in rabbits by maintaining them on a hyperlipidaemic diet after producing an endothelial lesion in the femoral arteries. Simultaneously, chronic arthritis was induced in these animals by repeated intraarticular injections of ovalbumin in previously immunized rabbits. A group of these rabbits were treated prophylactically with CS (100 mg kg(-1)day(-1)) and when the animals were killed, serum and peripheral blood mononuclear cells (PBMC) were isolated. Furthermore, femoral arteries and thoracic aorta were used for gene expression studies and histological examination. KEY RESULTS CS administration reduced the concentration of the proinflammatory molecules C-reactive protein and IL-6 in serum. Likewise, CS inhibited the expression of CCL2/monocyte chemoattractant protein (MCP)-1 and cyclooxygenase (COX)-2 in PBMC, and reduced the nuclear translocation of nuclear factor-kappaB. In the femoral lesion, CS also diminished the expression of CCL2 and COX-2, as well as the ratio of the intima/media thickness. Moreover, CS decreased the percentage of rabbits with atherosclerosis and chronic arthritis that developed vascular lesions in the aorta. CONCLUSIONS AND IMPLICATIONS These findings suggest that CS treatment may to some extent impede the progression of atherosclerosis.
Collapse
|
70
|
Sanghera DK, Nath SK, Ortega L, Gambarelli M, Kim-Howard X, Singh JR, Ralhan SK, Wander GS, Mehra NK, Mulvihill JJ, Kamboh MI. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Ann Hum Genet 2008; 72:499-509. [PMID: 18397358 DOI: 10.1111/j.1469-1809.2008.00443.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Recently, the transcription factor-7-like 2 (TCF7L2) gene has been identified as the most important type 2 diabetes mellitus (T2DM) susceptibility gene. Common intronic polymorphisms in this gene have been found to be strongly associated with T2DM susceptibility showing marked reproducibility in multiple populations. The purpose of this study was to confirm the reported association of six TCF7L2 variants in a Khatri Sikh diabetic sample from North India. We genotyped six-associated SNPs in a case-control sample consisting of 556 T2DM cases and 537 controls. We also examined the impact of these variants on body mass index (BMI), waist to hip ratio (WHR), fasting insulin, and glucose and lipid levels. We report replication of association of four of the six SNPs with T2DM in this Khatri Sikh sample [rs7903146, (p = 0.010); rs11196205, (p = 0.011); rs10885409, (p = 0.002) and rs4918789, (p = 0.029)], under a dominant model conferring odds ratios (ORs) of 1.39, 1.44, 1.57 and 1.36, respectively. Haplotype analysis provided further evidence of association by showing a significant difference between cases and controls as revealed by the global omnibus test (chi(2)= 19.36; p = 0.0036). Multiple linear regression analysis also revealed the risk allele carriers of three of four significant SNPs (rs7903146, rs11196205, rs10885409) to be significantly associated with increased fasting total cholesterol (p value = 0.019, 0.025, 0.006) and LDL cholesterol levels (p value = 0.021, 0.018, 0.005), respectively. Our findings confirm that the TCF7L2 gene is a major risk factor for development of T2DM in Khatri Sikhs. It also provides new information about the significant impact of TCF7L2 gene variants on plasma cholesterol levels that appear to be independent of BMI.
Collapse
|
71
|
López-Alonso G, Ágreda M, Devesa MJ, Cuenca F, Suárez A, Ortega L, Díaz-Rubio M, Ladero JM. Resultados del tratamiento de la hepatitis crónica por VHC genotipo 4: Un análisis comparativo con el genotipo 1. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2008; 100:208-11. [DOI: 10.4321/s1130-01082008000400003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
72
|
Ortega L, López F. Effects of visual flicker on subjective time in a temporal bisection task. Behav Processes 2008; 78:380-6. [PMID: 18358636 DOI: 10.1016/j.beproc.2008.02.004] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2007] [Revised: 01/25/2008] [Accepted: 02/04/2008] [Indexed: 11/19/2022]
Abstract
This experiment investigated the effects of visual flicker on subjective time in humans using a temporal bisection task. A 200-800 ms duration range and 400-1600 ms duration range were presented. Each duration range was presented separately in three different conditions: (1) filled stimuli were presented in both the training and the testing phases, (2) flickering stimuli were presented in the training phase and filled stimuli were presented in the testing phase, and (3) filled stimuli were presented in the training phase and flickering stimuli were presented in the testing phase. Psychophysical functions displacements and bisection point values suggested that flicker increased the speed of the clock; however the direction of the displacement and bisection point changes depended on the phase of the task in which the flicker was presented. This result agrees with the specific storage in either working or reference memory components of Scalar Expectancy Theory of the increased number of pulses from the clock. Weber fractions and difference limens suggested that flicker did not affect subjects' temporal sensitivity.
Collapse
|
73
|
Ortega L, Santoyo E, Gual A. Erectile dysfunction in alcoholic patients. Results of an observational study carried out in an alcohol treatment centre. Eur Psychiatry 2007. [DOI: 10.1016/j.eurpsy.2007.01.624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
74
|
Kilmurray LG, Ortega L, Martínez A, Sanz Esponera J. Neurofibroma with psammoma bodies. Histol Histopathol 2006; 21:965-8. [PMID: 16763946 DOI: 10.14670/hh-21.965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Neurofibromas are benign tumours of the nerve sheath. Histologically they vary depending on their contents of cells, myxoid stroma and collagen. A 41-year old male with radicular pain had a tumour involving the posterior chest wall. Microscopically it resulted to be a neurofibroma with abundant psammoma bodies. Although these bodies are very frequent in some neoplasias, to our knowledge they have not been described in neurofibromas to date.
Collapse
|
75
|
Baldé MD, Ecke JE, Ortega L, Caulet-Maugendre LS, Chabanne C, Almange C, Daubert JC, Leguerrier A, Laurent M. [Valve replacement for aortic regurgitation associated with rheumatoid arthritis: a series of 5 cases]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX 2006; 99:569-74. [PMID: 16878716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
Between 30 and 50% of patients with rheumatoid arthritis (RA) have cardiac involvement but only 2 to 10% have clinical manifestations. The authors report the results of a retrospective study of 5 cases of aortic regurgitation (AR) requiring valve replacement. There were 4 women and 1 man with an average age of 48.4 years. The average duration of the RA was 19.6 years. All patients had cardiac failure. Aortic valve replacement was performed in all cases, with bioprostheses in 4 out of 5 patients. The histopathological examination of the valves showed a rheumatoid nodule in 3 cases and non-specific lesions in one case. In the fifth patient, rheumatoid serology was positive in the pericardial effusion. The average interval between the onset of symptoms and cardiac surgery was 3.6 months (range 1 to 6 months) There were 3 deaths at 3 days, 20 months and 10 years, two patients survive after 12 and 14 years. The characteristic rapid progression of this form of AR, which may be life-threatening, should be emphasised.
Collapse
|